Ignite Creation Date:
2024-05-06 @ 7:42 AM
Last Modification Date:
2024-10-26 @ 11:51 AM
Study NCT ID:
NCT02584634
Status:
TERMINATED
Last Update Posted:
2023-07-07
First Post:
2015-10-21
Brief Title:
Study to Evaluate Safety Efficacy Pharmacokinetics And Pharmacodynamics Of Avelumab In Combination With Either Crizotinib Or PF-06463922 In Patients With NSCLC Javelin Lung 101
Sponsor:
Pfizer
Organization:
Pfizer